Download presentation
Presentation is loading. Please wait.
Published byVincent Lang Modified over 6 years ago
1
What’s the link? Shared embryological origin (ectoderm +/- enoderm)
Shared functions Continuation of the skin First manifestation of dermatological conditions Essential part of dermatological examination
2
stratified squamous epithelium
Oral mucosa Skin
4
Congenital Acquired
5
Pigmented White lesions Red lesions Swellings Ulcers Blisters Teeth anomalies
6
Importance Common Serious First manifestation
Associations- cross referrals
7
Lichen planus
8
Reticular Erosive Bullous Atrophic Plaque-form papular
9
0.2% of populations 25% skin and oral LP- erosive, lichenoid HCV, amalgam, GvHD Drugs; B-blockers, calcium channel blockers, NSAIDS, ACE-inihibitors Mostly buccal mucosa and lateral tongue Symmetrical Lasts longer than skin lesions average 8 years Can be asymptomatic
10
Chlorhexidine mouth wash
Betnesol mouth rinses 0.5mg in 10ml Calcineurin inhibitors Oral steroids Hydroxychloroquine MMF Azathioprine, dapsone, Mtx Rituximab
11
Importance Associated scarring- microstomia Risk of malignancy
Related to amalgum/HCV/drugs Associations: Skin Vulva Eyes Ears
12
DSG3 +/- DSG1 Earlier mucosal involvement 50-70% (average 5 months) Drugs- anti-TB, ACE inhibitors, captopril, rifampicin Less intact vesicles or bullae Irregular ulcers- ginigivae, buccal, palatal areas No scarring
13
Used to be fatal now 5-15% Steroids Azathioprine MMF Rituximab Complete remission ?10 years in 75%
14
Importance Associations: eye , genital, skin Paraneoplastic pemphigus
16
Oral Apthae
17
Behcet Disease
18
Importance Associations Genital ulcers Ocular manifestations Aneurysms
Coagulapathy GI/CNS
19
Importance Rule out allergens
Differentials: TB, sracoidosis, crohn’s disease Can become permanent
20
Erythema Multiforme EM minor EM minor with extramucosal involvement
SJS- Stevens Johnson Syndrome TEN- toxic epidermal necrolysis Infection- HSV, mycoplasma Drug- anticonvulsants
21
SCORTEN
22
Importance EM- common TEN- Fatal Need to stop offending drug
Sequelae ie scarring Supportive Immunomodulation IVIG
23
Importance Associations: Scarring Systemic involvement
Antiphospholipid syndrome
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.